SecBot SecBot

XCUR

EXICURE, INC.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001698530 Biotech & Drug Discovery
$1.09 +0.04 (+3.33%)
Oct 26 4:00 PM ET · prev $1.05
Market cap
$7.4M
Nano cap
Next earnings
Nov 5
in 10 days
1 year
−76.8%
from $4.68 · Oct 27
30 days
−12.1%
from $1.24
52-week range
$0.9990–7.29
−85% from high · low Oct 20
Avg volume 20D
61.9K
Oct 22 spike 440.0K
Short interest
37.6K
≈0.6% of shares · −46.9%
Days to cover
2.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
4
analyzed by SecBot
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·Next Earnings date, Nov 5, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 2 trimmed or exited.

  • Short sellersCOVERING

    Short interest −46.9% to 37.6K shares. 2.0 days to cover, ≈0.6% of shares.

  • TrendDOWNTREND

    11% below its 50-day average. New closing low $0.9990 on Oct 20.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD CAPITAL MANAGEMENT LLCADD43,111$89.7K
UBS Group AGTRIM342$711.00
BlackRock, Inc.NEAR_EXIT35$73.00
BlackRock, Inc.DOUBLED9,353$39.8K
UBS Group AGTRIM866$3.7K
MORGAN STANLEYNEAR_EXIT158$672.00
Carlyle Group Inc.NEAR_EXIT56,328$304.7K
BlackRock, Inc.TRIM4,175$22.6K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Aug 2022
Recent actions
DateFirmActionRating
Aug 16, 2022Chardan Capital
MAINTAIN
MAINTAINNeutral

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jul 8, 2026
Exicure HiTron Inc.
10%+ Owner
OTHER$528.5K
Jun 26, 2026
Exicure HiTron Inc.
10%+ Owner
OTHER$1.1M
Jun 24, 2026
Exicure HiTron Inc.
10%+ Owner
OTHER$555.6K
Jun 23, 2026
Exicure HiTron Inc.
10%+ Owner
OTHER$581.3K

Earnings setup

Estimates
Nov 5
reports in 10 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
37,561
shares short
-46.9%
vs prior settlement
2.0
days to cover
≈0.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 16, 2026 SEC
Exicure, Inc. filed an 8-K with Item 3.01 disclosing a delisting notice from Nasdaq. The company received notice that…
8-K — Impact 7/10
Aug 6, 2026 Earnings calendar
XCUR Q2 2026 Earnings Scheduled — 2026-08-06
Jul 8, 2026 Insider
Exicure HiTron Inc. acquired 117,441 shares
10%+ Owner @ $4.50 ($528.5K)
Jun 30, 2026 SEC
Exicure, Inc. reported the resignation of director Ham Jung Kyu (effective June 30, 2026), a board size increase from…
8-K — Impact 2/10
Jun 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC — ADD
43,111 shares ($89.7K)
Jun 30, 2026 Inst.
UBS Group AG — TRIM
342 shares ($711.00)
Jun 26, 2026 Insider
Exicure HiTron Inc. acquired 253,195 shares
10%+ Owner @ $4.50 ($1.1M)
Jun 24, 2026 Insider
Exicure HiTron Inc. acquired 123,456 shares
10%+ Owner @ $4.50 ($555.6K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Aug 6, 2026
Earnings date
XCUR Q2 2026 Earnings Scheduled — 2026-08-06
Jun 30, 2026
Press release
Exicure Announces Board and Committee Changes
Exicure announced Board and committee changes, including two director appointments, one resignation, and the formation of a Compensation Committee.
Jun 25, 2026
Earnings date
XCUR Q1 2026 Earnings Scheduled — 2026-06-25
Jun 10, 2026
Press release
Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
Exicure received a Nasdaq notice regarding non-compliance with the minimum stockholders’ equity requirement and plans to regain compliance.
Jun 1, 2026
Regulatory
Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q
Exicure announced receipt of a Nasdaq notice related to the delayed filing of its Form 10-Q and confirmed that the Form 10-Q was filed on May 29…

SecBot reports

4 filings · 2 press releases · 0 bullish · 1 bearish · 3 neutral
All XCUR filing & press-release reports (6)